Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Fair Value of Our Financial Assets and Liabilities

The following table summarizes the fair value of our financial assets and liabilities that were accounted for at fair value on a recurring basis, by level within the fair value hierarchy:

	March 31, 2024
	Level 1		Level 2		Level 3		Fair Value
Assets:
Cash equivalents:
Money market funds		37,124		-		-		37,124
Foreign exchange contracts receivable				99		-		99
		37,124		99		-		37,223
Liabilities:
Contingent consideration						153		153
Private Placement Warrants						36,755		36,755
		-				36,908		36,908

	December 31, 2023
	Level 1		Level 2		Level 3		Fair Value
Assets:
Cash equivalents:
Money market funds		11,377		-		-		11,377
Foreign exchange contracts receivable				256		-		256
		11,377		256		-		11,633
Liabilities:
Contingent consideration		-		-		155		155
		-		-		155		155

Schedule of Fair Value Level 3 financial liabilities

The changes in the fair value of the Company’s Level 3 financial liabilities, which are measured on a recurring basis are as follows:

	Three Months Ended March 31, 2024		Three Months Ended March 31, 2023
Beginning balance	-		-
Private Placement Warrants		28,745		-
Revaluation recorded in financial expense		8,010		-
Ending balance		36,755		-

Schedule of Fair Value of the Liabilities for the Private Placement Warrants

The main assumptions used are as follows:

	Three Months Ended March 31,
	2024		2023
Underlying value of Common Stock ($)		0.37-0.45		-
Exercise price ($)		0.23		-
Expected volatility (%)		117.7-117.8		-
Expected terms (years)		2.3-2.25		-
Risk-free interest rate (%)		4.5-4.6		-